Bedau T, Zander T, Anton Schlosser H, Alakus H, et al. MET Expression in Upper Gastrointestinal Adenocarcinoma: Prevalence, Prognostic Impact, and Implications for Anti-MET Antibody-Drug Conjugate Therapy. Int J Cancer 2026;159:2606-2618.
PMID: 42394136